Bank of New York Mellon’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-7,031
| Closed | -$19K | – | 4353 |
|
2019
Q1 | $19K | Sell |
7,031
-214
| -3% | -$578 | ﹤0.01% | 4158 |
|
2018
Q4 | $15K | Hold |
7,245
| – | – | ﹤0.01% | 4173 |
|
2018
Q3 | $33K | Hold |
7,245
| – | – | ﹤0.01% | 4161 |
|
2018
Q2 | $33K | Sell |
7,245
-2,843
| -28% | -$12.9K | ﹤0.01% | 4129 |
|
2018
Q1 | $72K | Buy |
10,088
+1,933
| +24% | +$13.8K | ﹤0.01% | 4098 |
|
2017
Q4 | $59K | Buy |
8,155
+910
| +13% | +$6.58K | ﹤0.01% | 4167 |
|
2017
Q3 | $60K | Sell |
7,245
-589
| -8% | -$4.88K | ﹤0.01% | 4081 |
|
2017
Q2 | $80K | Buy |
7,834
+59
| +0.8% | +$603 | ﹤0.01% | 4064 |
|
2017
Q1 | $90K | Buy |
7,775
+530
| +7% | +$6.14K | ﹤0.01% | 4047 |
|
2016
Q4 | $92K | Sell |
7,245
-538
| -7% | -$6.83K | ﹤0.01% | 4038 |
|
2016
Q3 | $142K | Sell |
7,783
-1,250
| -14% | -$22.8K | ﹤0.01% | 3968 |
|
2016
Q2 | $96K | Sell |
9,033
-20,345
| -69% | -$216K | ﹤0.01% | 4065 |
|
2016
Q1 | $555K | Sell |
29,378
-604
| -2% | -$11.4K | ﹤0.01% | 3391 |
|
2015
Q4 | $798K | Buy |
29,982
+150
| +0.5% | +$3.99K | ﹤0.01% | 3299 |
|
2015
Q3 | $1.36M | Sell |
29,832
-6,153
| -17% | -$281K | ﹤0.01% | 2978 |
|
2015
Q2 | $1.16M | Buy |
35,985
+2,242
| +7% | +$72.2K | ﹤0.01% | 3250 |
|
2015
Q1 | $1.07M | Sell |
33,743
-3,380
| -9% | -$108K | ﹤0.01% | 3266 |
|
2014
Q4 | $1.4M | Sell |
37,123
-1,242
| -3% | -$46.9K | ﹤0.01% | 3094 |
|
2014
Q3 | $1.01M | Buy |
38,365
+5,281
| +16% | +$139K | ﹤0.01% | 3277 |
|
2014
Q2 | $980K | Buy |
33,084
+2,590
| +8% | +$76.7K | ﹤0.01% | 3322 |
|
2014
Q1 | $1.13M | Sell |
30,494
-1,741
| -5% | -$64.4K | ﹤0.01% | 3207 |
|
2013
Q4 | $1.34M | Sell |
32,235
-32
| -0.1% | -$1.33K | ﹤0.01% | 3124 |
|
2013
Q3 | $1.71M | Buy |
32,267
+550
| +2% | +$29.2K | ﹤0.01% | 2935 |
|
2013
Q2 | $1.69M | Buy |
+31,717
| New | +$1.69M | ﹤0.01% | 2893 |
|